RAFAEL HOLDINGS, INC. Available-for-sale Securities, Gross Realized Gains
RAFAEL HOLDINGS, INC. (RFL) reported Available-for-sale Securities, Gross Realized Gains of $330.00 thousand for the 12-month period ending 2019-07-31, per its 10-K filed 2020-10-29.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2020-10-29
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for the quarter ending 2019-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for the quarter ending 2019-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for the quarter ending 2019-01-31 was $103.00K.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-10-31 was $10.00K.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for fiscal 2019 was $330.00K, a 2650.00% increase from fiscal 2018.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for fiscal 2018 was $12.00K.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross realized gains for fiscal 2017 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 9 month | Available-for-sale Securities, Gross Realized Gains 12 month |
|---|---|---|---|---|
| 2019-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $103.00K derived: sum of 3 quarters · filed 2020-10-29 | $330.00K 10-K · filed 2020-10-29 |
| 2019-04-30 | $0.00 10-Q · filed 2019-06-05 | $103.00K derived: sum of 2 quarters · filed 2019-06-05 | $330.00K 10-Q · filed 2019-06-05 | $101.00K derived: sum of 4 quarters · filed 2019-10-04 |
| 2019-01-31 | $103.00K 10-Q · filed 2019-03-12 | $330.00K 10-Q · filed 2019-03-12 | $101.00K derived: sum of 3 quarters · filed 2019-10-04 | $125.00K derived: sum of 4 quarters · filed 2019-10-04 |
| 2018-10-31 | $10.00K 10-Q · filed 2018-12-10 | -$2.00K derived: sum of 2 quarters · filed 2019-10-04 | $22.00K derived: sum of 3 quarters · filed 2019-10-04 | $22.00K derived: sum of 4 quarters · filed 2019-10-04 |
| 2018-07-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $12.00K derived: sum of 2 quarters · filed 2019-10-04 | $12.00K derived: sum of 3 quarters · filed 2019-10-04 | $12.00K 10-K · filed 2019-10-04 |
| 2018-04-30 | $24.00K 10-Q · filed 2019-06-05 | $24.00K derived: sum of 2 quarters · filed 2019-06-05 | $24.00K 10-Q · filed 2019-06-05 | $24.00K derived: sum of 4 quarters · filed 2019-06-05 |
| 2018-01-31 | $0.00 10-Q · filed 2019-03-12 | $0.00 10-Q · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $0.00 derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-10-31 | $0.00 10-Q · filed 2018-12-10 | $0.00 derived: sum of 2 quarters · filed 2018-12-10 | $0.00 derived: sum of 3 quarters · filed 2018-12-10 | |
| 2017-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $0.00 derived: sum of 2 quarters · filed 2018-10-15 | $0.00 10-K · filed 2018-10-15 | |
| 2017-04-30 | $0.00 10-Q · filed 2018-06-11 | $0.00 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |